Corrigendum: (-)-Epigallocatechin-3-Gallate ameliorates atherosclerosis and modulates hepatic lipid metabolic gene expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B [Front. Pharmacol., 9, (195) (2018)] DOI: 10.3389/fphar.2018.00195

21Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The authorship of this article should be correctly ordered to protect the right ownership of this paper. In addition, Dr. Li-Long Pan has contributed significantly to this study, such that Dr. Pan should be the co-corresponding author in this study. The authorship order should be considered as follows.

Cite

CITATION STYLE

APA

Wang, W., Zhang, Z. Z., Wu, Y., Wang, R. Q., Chen, J. W., Chen, J., … Pan, L. L. (2018, May 1). Corrigendum: (-)-Epigallocatechin-3-Gallate ameliorates atherosclerosis and modulates hepatic lipid metabolic gene expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B [Front. Pharmacol., 9, (195) (2018)] DOI: 10.3389/fphar.2018.00195. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2018.00459

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free